Studies from Saint James School of Medicine Yield New Data on Cancer (Postbiotics as Adjuvant Therapy in Cancer Care).

A recent study from the Saint James School of Medicine explores the potential of postbiotics as adjuvant therapy in cancer care. Postbiotics are defined as preparations of inanimate microorganisms and/or their components that provide health benefits to the host. The study suggests that postbiotics may influence carcinogenesis through various mechanisms, such as promoting immune responses, reducing inflammation, and inducing cytotoxicity against tumor cells. However, the lack of consistent clinical evidence supporting postbiotics' efficacy is attributed to their poor bioavailability and fluctuating levels. The researchers propose that synbiotics, a combination of prebiotics and probiotics, may have greater potential for future development in cancer treatment. [Extracted from the article]